Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3112379 Target Snapshot

Phosphatidylcholine:ceramide cholinephosphotransferase 2 · SINGLE PROTEIN · Homo sapiens

148Compounds
30Assays
0Approved Drugs
145.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q8NHU3. Use UniProt Q8NHU3 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8NHU3 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Phosphatidylcholine:ceramide cholinephosphotransferase 2 as ChEMBL target CHEMBL3112379, mapped to UniProt Q8NHU3. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Phosphatidylcholine:ceramide cholinephosphotransferase 2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3112379
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q8NHU3
Phosphatidylcholine:ceramide cholinephosphotransferase 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Phosphatidylcholine:ceramide cholinephosphotransferase 2 is the right protein anchor across sources, using UniProt Q8NHU3 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPhosphatidylcholine:ceramide cholinephosphotransferase 2
UniProt AccessionQ8NHU3
Component TypeProtein
Sequence Length365 aa

Phosphatidylcholine:ceramide cholinephosphotransferase 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Phosphatidylcholine:ceramide cholinephosphotransferase 2, mapped to UniProt Q8NHU3. Sequence length is 365 aa.

Mapped IDQ8NHU3
Review namePhosphatidylcholine:ceramide cholinephosphotransferase 2
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC50139.0
KD6.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4172856 8.19 IC50 6.5 Preclinical
CHEMBL4177314 7.8 IC50 16.0 Preclinical
CHEMBL4172856 7.55 Kd 28.0 Preclinical
CHEMBL4646354 7.52 IC50 30.0 Preclinical
CHEMBL4645607 7.35 IC50 45.0 Preclinical
CHEMBL4641888 7.33 IC50 47.0 Preclinical
CHEMBL4203399 7.05 IC50 90.0 Preclinical
CHEMBL4540510 7.04 IC50 91.0 Preclinical
CHEMBL4638337 7.04 IC50 91.0 Preclinical
CHEMBL4204352 7.0 IC50 100.0 Preclinical
Distribution

pChEMBL Value Distribution

10
5.0
25
5.5
29
6.0
12
6.5
8
7.0
4
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

30
Total Assays
115
Tested Compounds
1
Assay Types
Binding — 30 assays, 115 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 21 43 5.8
single protein format 7 36 6.0
subcellular format 2 36 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine